The effects of prophylactic use of esketamine on postoperative depression and quality of life: a meta-analysis.
Guoweng Niu, Xiaozhu Zheng, Bigao Deng, Yong S Du, Yang Mei
Minerva anestesiologica April 1, 2024 DOI: 10.23736/S0375-9393.24.17703-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review and meta-analysis Randomized Peer reviewed |
|---|---|
| Sample size | 1,447 |
| Population | Patients undergoing surgery |
| Intervention | Esketamine |
| Topics | Depression Esketamine |
| Keywords | Surgery Mental health Pain management Anesthesia |
| Citations | 17 |
| Key findings | Prophylactic esketamine alleviates postoperative depressive symptoms and reduces the incidence of depression, anxiety, and chronic pain while improving sleep quality and quality of life. |
Abstract
The aim of this systemic review and meta-analysis was to assess the impact of prophylactic use of esketamine on postoperative depression and quality of life in patients. We searched for all articles on esketamine in patients after surgury in electronic data bases, including PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, up to the June 2023.The included studies compared the impact of using esketamine and placebo on postoperative depression and quality of life in patients through randomized controlled trials. The outcome measurements consist of postoperative depression and indicators that can reflect the impact on patients' post Cochrane Risk of Bias tool in Review Manager 5.4 tool was adopted to assess the risk of bias. The study included a total of 11 randomized controlled trials with 1447 participants. This meta-analysis demonstrated that the prophylactic use of esketamine alleviated postoperative depressive symptoms (standardized mean difference [SMD]: -0.61; 95% confidence interval [CI]: -0.96 to -0.25; P=0.0008) and incidence (relative risk [RR]:0.37;95% [CI]: 0.22 to 0.62; P=0.0001), reducing the occurrence of postoperative depression, anxiety, and chronic pain. Additionally, it improved postoperative sleep quality and enhanced the postoperative quality of life for patients. Prophylactic use of esketamine during the preoperative and anesthesia period has shown significant benefits in improving postoperative quality of life. It can effectively alleviate postoperative depression, anxiety, and chronic pain, as well as enhance sleep quality.